Medicaid

Coy Gupta Joins Glytec as Chief Technology Officer to Innovate and Enhance AI Capabilities of Industry Leading Medical Software Platform

BOSTON, April 24, 2025 /PRNewswire/ -- Glytec, the Software-as-a-Service (SaaS) technology leader and pioneer in diabetes and insulin management, is proud...

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

Proposed bipartisan legislation would expand Medicare reimbursement pathways for AI-enabled medical devices — a framework that supports Nexalin’s Gen-3 HALO...

Exiger Report Shows Urgent Risk to U.S. Healthcare and Dangerous Dependence on China-Made Pharmaceuticals, with One-Third of Antibiotics Traced to Forced Labor

Proprietary data and AI analysis examines how America's pharmaceutical supply chains carry hidden risks to consumers WASHINGTON, April 15, 2025...

LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs

LifeMD’s virtual care services now available to over 21 million Medicare Part B beneficiaries in 26 states, with 49-state access...

EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications

New ICD-10 Codes Recognize Fontan-Associated Conditions, Advancing Care and Coverage for Rare Congenital Heart Disease Community

SEOUL, South Korea, April 16, 2025 /PRNewswire/ -- Mezzion Pharmaceuticals, a global leader in the development of therapies for patients with...

error: Content is protected !!